Welcome to our dedicated page for Astrotech news (Ticker: ASTC), a resource for investors and traders seeking the latest updates and insights on Astrotech stock.
Astrotech Corporation develops instrumentation businesses built around mass spectrometry and gas chromatography technologies through wholly owned subsidiaries. News about ASTC commonly covers 1st Detect and its TRACER 1000 trace detection systems for aviation security, explosives screening, and narcotics detection, including regulatory certifications, deployments, and security-market applications.
Company updates also address AgLAB process analyzers for agriculture products, Pro-Control industrial chemical process control, BreathTech breath-analysis work for volatile organic compounds, and EN-SCAN portable environmental GC-MS for field testing of air, water, and soil. Recurring releases include fiscal results, research and development progress, sales activity, leadership appointments, and board-level strategic or governance actions.
Astrotech (NASDAQ:ASTC) announced its participation in the upcoming H.C. Wainwright 27th Annual Global Investment Conference. The company's leadership team, including Chairman and CEO Thomas B. Pickens III and CFO Jennifer Cañas, will conduct investor meetings on September 9, 2025 at the Lotte New York Palace Hotel in New York City.
Interested investors can schedule meetings through their H.C. Wainwright representative or by contacting Astrotech's Investor Relations directly.
Astrotech Corporation (NASDAQ: ASTC) announced the first sale and deployment of its TRACER 1000™ Narcotics Trace Detector in Vietnam through its subsidiary 1st Detect. This expansion into Southeast Asia represents a strategic milestone in the company's global growth.
The TRACER 1000 NTD™ system, which utilizes Mass Spectrometry technology, provides confirmatory trace narcotics detection with near-zero false alarm rates. CEO Tom Pickens highlighted that the global narcotics and explosives trace detection market is valued at over $7 billion and is experiencing rapid growth due to increasing demand for innovative security solutions.
Astrotech Corporation (NASDAQ: ASTC) has appointed Jennifer Cañas as its new Chief Financial Officer, effective May 22, 2025. Cañas, who has served as the Company's Corporate Controller since June 2022, brings over 20 years of senior financial experience to the role. Prior to joining Astrotech, she was Controller at The Texas Water Company (2018-2022) and founded a tax and financial advisory firm. She also has experience at PricewaterhouseCoopers and other accounting firms.
A Certified Public Accountant, Cañas graduated with honors from the University of Houston – Clear Lake with a BS in accounting. She is actively involved in community service through Big Brothers Big Sisters and Financial Peace University. Chairman and CEO Thomas B. Pickens III praised Cañas' leadership and competence, expressing confidence in her ability to deliver value for shareholders.
Astrotech (NASDAQ: ASTC) reported its Q3 FY2025 financial results, showing significant revenue growth to $534,000 compared to $50,000 in Q3 FY2024. The revenue came from TRACER 1000™ shipments, a government grant, and recurring sales. The company maintains a strong balance sheet with $20.9 million in cash and investments, down from $31.9 million in June 2024.
Key developments include a DHS R&D contract for the TRACER 1000, a $429,000 purchase order from Intuitive Research, the creation of EN-SCAN subsidiary for environmental testing, and the configuration of TRACER 1000 NTD for synthetic opiate detection. The company's mass spectrometry instruments are now deployed in 15 countries for explosive trace detection, with expanded applications in narcotics detection, environmental monitoring, and chemical processing.
["Revenue increased significantly to $534,000 in Q3 FY2025 from $50,000 in Q3 FY2024", "Secured DHS R&D contract for TRACER 1000 development", "Received $429,000 purchase order from TSA contractor", "Strong balance sheet with $20.9 million in cash and investments", "Expanded market presence with products deployed in 15 countries"]Astrotech (ASTC) has announced the launch of an enhanced version of its TRACER 1000™ Narcotics Trace Detector through its 1st Detect subsidiary. The upgraded device is specifically designed to detect synthetic opiates and novel psychoactive substances (NPS).
The enhanced TRACER 1000 NTD utilizes advanced mass spectrometry technology to identify minute traces of illicit substances, including fentanyl analogs and emerging synthetic drugs. Key features include:
- Full-spectrum screening capabilities
- High precision and sensitivity detection
- Rapid analysis with results in seconds
- User-friendly interface with minimal training requirements
According to Thomas B. Pickens, III, Chairman and CEO of 1st Detect, this launch represents significant progress in combating synthetic opiates and NPS. The device is now available for deployment across security, public safety, and healthcare sectors.
Astrotech (NASDAQ: ASTC) has announced the creation of a new wholly owned subsidiary, EN-SCAN, focused on manufacturing environmental testing instruments using proprietary ATi Gas Chromatograph and Astrotech Mass Spectrometer Technology.
The company will introduce three new products at PITTCON 2025 in Boston:
- EN-SCAN Rugged-Lab GC-MS: A transportable system for on-site analysis of air, water, and soil
- EN-SCAN Fenceline Monitor: A continuous emissions monitoring system for detecting pollutants like BTEX at refineries
- EN-SCAN Handheld GC: A portable device for detecting volatile organic compounds and contaminants
The product line is designed for outdoor field work, providing real-time analysis and instant feedback for contamination source location and migration in demanding environments.
Astrotech (NASDAQ: ASTC) reported Q2 FY2025 financial results with revenue of $295 thousand, primarily from activities with the U.S. Department of Homeland Security (DHS) for the TRACER 1000™ explosives trace detection system. The company maintains a strong balance sheet with $24.7 million in cash and liquid investments.
Key developments include a new R&D contract (70RSAT24CB0000015) with DHS for the TRACER 1000 and a purchase order from Intuitive Research and Technology , a TSA contractor. The company's 1st Detect subsidiary has expanded its product line to include narcotics trace detection, particularly focusing on fentanyl identification, and introduced Pro-Control products for chemical manufacturing process optimization.
The TRACER 1000 has demonstrated success with four years of operational history in cargo warehouses across 14 countries, processing thousands of samples.
Astrotech (NASDAQ: ASTC) announced the resignation of Chief Financial Officer Jaime Hinojosa, effective February 14, 2025. Hinojosa will transition to work in his family business in Houston, while continuing to provide consulting services to Astrotech through June 30, 2025.
The company has appointed Ryan Polk as interim Chief Financial Officer, effective February 14, 2025. Polk brings experience as CFO in both public and private entities, with expertise in scaling companies through organic growth and acquisition.
CEO Tom Pickens acknowledged Hinojosa's contributions to the company's financial and regulatory reporting, as well as his dedication to employees, customers, and suppliers.
Astrotech (NASDAQ: ASTC) announced that its subsidiary 1st Detect has secured its first purchase order for TRACER 1000™ explosive trace detectors (ETDs) from Intuitive Research and Technology , a TSA contractor. The order is valued at $429K and is expected to be recognized in FY2025.
The TRACER 1000, powered by Astrotech Mass Spectrometer Technology™, is the first TSA-approved ETD utilizing mass spectrometry technology. This breakthrough enables laboratory-level analysis with near-zero false alarms and an unlimited detection library, making previously laboratory-confined mass spectrometry technology practical for field use.
Astrotech (NASDAQ: ASTC) and its subsidiary 1st Detect have secured a research and development contract from the U.S. Department of Homeland Security (DHS) to enhance their TRACER 1000 explosives trace detection system. The contract, numbered 70RSAT24CB0000015, aims to develop improved detection capabilities against evolving security threats.
The project is structured in two 15-month phases with a total potential value of $1,290,650. Phase 1 is valued at $581,639, while Phase 2, which is optional and dependent on successful completion of Phase 1, is worth $709,011. The entire project spans 30 months and aligns with DHS's Long Range Broad Agency Announcement No. 18-01 objectives.